生物材料进展 SCIE

期刊简介预计审稿时间：约Review Process, 7.2 weeks; Acceptance to First Online, 0.7 weeks Review Process, 7.2 weeks; Acceptance to First Online, 0.7 weeks 约7.2 weeks

Biomaterials Advances, previously known as Materials Science and Engineering: C-Materials for Biological Applications (P-ISSN: 0928-4931, E-ISSN: 1873-0191). Includes topics at the interface of the biomedical sciences and materials engineering. These topics include:

• Bioinspired and biomimetic materials for medical applications

• Materials of biological origin for medical applications

• Materials for "active" medical applications

• Self-assembling and self-healing materials for medical applications

• "Smart" (i.e., stimulus-response) materials for medical applications

• Ceramic, metallic, polymeric, and composite materials for medical applications

• Materials for in vivo sensing

• Materials for in vivo imaging

• Materials for delivery of pharmacologic agents and vaccines

• Novel approaches for characterizing and modeling materials for medical applications

Manuscripts on biological topics without a materials science component, or manuscripts on materials science without biological applications, will not be considered for publication in Materials Science and Engineering C. New submissions are first assessed for language, scope and originality (plagiarism check) and can be desk rejected before review if they need English language improvements, are out of scope or present excessive duplication with published sources.

Biomaterials Advances sits within Elsevier's biomaterials science portfolio alongside Biomaterials, Materials Today Bio and Biomaterials and Biosystems. As part of the broader Materials Today family, Biomaterials Advances offers authors rigorous peer review, rapid decisions, and high visibility. We look forward to receiving your submissions!

《生物材料进展》，原名为《材料科学与工程：生物应用的 C 材料》（P-ISSN：0928-4931，E-ISSN：1873-0191）。包括生物医学科学与材料工程交叉领域的主题。这些主题包括：

• 用于医疗应用的生物启发和仿生材料

• 用于医疗应用的生物来源材料

• 用于“主动”医疗应用的材料

• 用于医疗应用的自组装和自修复材料

• 用于医疗应用的“智能”（即刺激-反应）材料

• 用于医疗应用的陶瓷、金属、聚合物和复合材料

• 用于体内传感的材料

• 用于体内成像的材料

• 用于药剂和疫苗输送的材料

• 用于医疗应用的材料表征和建模的新方法

没有材料科学成分的生物学主题手稿或没有生物学应用的材料科学手稿将不考虑在材料科学与工程 C 上发表。新提交的文章首先会根据语言、范围和原创性（抄袭检查），如果需要改进英语语言、超出范围或与已发表的资料存在过多重复，则可在审查前被拒绝。

Biomaterials Advances 与 Biomaterials、Materials Today Bio 和 Biomaterials and Biosystems 一起属于 Elsevier 的生物材料科学组合。作为更广泛的 Materials Today 家族的一部分，Biomaterials Advances 为作者提供严格的同行评审、快速决策和高知名度。我们期待收到您的投稿！

《Biomaterials Advances》(生物材料进展)编辑部通讯方式为ELSEVIER, RADARWEG 29, AMSTERDAM, NETHERLANDS, 1043 NX。如果您需要协助投稿或润稿服务，您可以咨询我们的客服老师。我们专注于期刊投稿服务十年，熟悉发表政策，可为您提供一对一投稿指导，避免您在投稿时频繁碰壁，节省您的宝贵时间，有效提升发表机率，确保SCI检索（检索不了全额退款）。我们视信誉为生命，多方面确保文章安全保密，在任何情况下都不会泄露您的个人信息或稿件内容。